Canagliflozin | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Canagliflozin
HEALTH CANADA PATENTS

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Canagliflozin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

60 API Suppliers, 27 USDMF, 7 EU WC, 14 NDC API, 41 Listed Suppliers, $ API Reference Price

60 API Suppliers
27 USDMF
7 EU WC
14 NDC API
41 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

INTERMEDIATES

39 Intermediates Suppliers

39 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

54 FDF Dossiers, 15 FDA Orange Book, 20 Europe, 6 Canada, 13 Listed Dossiers

54 FDF Dossiers
15 FDA Orange Book
20 Europe
6 Canada
13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 150MG;1GM, TABLET, EXTENDED RELEASE;ORAL - 150MG;500MG, TABLET, EXTENDED RELEASE;ORAL - 50MG;1GM, TABLET, EXTENDED RELEASE;ORAL - 50MG;500MG

TABLET, EXTENDED RELEASE;ORAL - 150MG;1GM
TABLET, EXTENDED RELEASE;ORAL - 150MG;500MG
TABLET, EXTENDED RELEASE;ORAL - 50MG;1GM
TABLET, EXTENDED RELEASE;ORAL - 50MG;500MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 Seqens, 3 DKSH, 1 Jai Radhe Sales, 2 Faran Shimi Pharmaceutical, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 23 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

49 Coating Systems & Additives, 31 Fillers, Diluents & Binders, 28 Controlled & Modified Release, 17 Direct Compression, 16 Disintegrants & Superdisintegrants, 15 Thickeners and Stabilizers, 13 Lubricants & Glidants, 11 Granulation, 9 Co-Processed Excipients, 9 Topical, 8 Film Formers & Plasticizers, 5 Empty Capsules, 5 Coloring Agents, 5 Solubilizers, 4 Parenteral, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 3 Rheology Modifiers, 3 Chewable & Orodispersible Aids, 2 Emulsifying Agents

49 Coating Systems & Additives
31 Fillers, Diluents & Binders
28 Controlled & Modified Release
17 Direct Compression
16 Disintegrants & Superdisintegrants
15 Thickeners and Stabilizers
13 Lubricants & Glidants
11 Granulation
9 Co-Processed Excipients
9 Topical
8 Film Formers & Plasticizers
5 Empty Capsules
5 Coloring Agents
5 Solubilizers
4 Parenteral
4 Vegetarian Capsules
4 API Stability Enhancers
4 Taste Masking
3 Rheology Modifiers
3 Chewable & Orodispersible Aids
2 Emulsifying Agents

DIGITAL CONTENT

11 DATA COMPILATION #PharmaFlow, 139 NEWS #PharmaBuzz

11 DATA COMPILATION #PharmaFlow
139 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 20 Finished Drug Prices, 37 Annual Reports

2 US Medicaid Prescriptions
20 Finished Drug Prices
37 Annual Reports

MARKET PLACE

18 APIs, 2 FDF Dossiers

18 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

130 US Patents, 4 Health Canada Patents

130 US Patents
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

13 Others

13 Others

$ API Ref.Price (USD/KG) : 2,753 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Belmore Neidrauer LLP

filter Patent Reset all filters

4 All

01 22534024

02 22671357

filter Product Reset all filters

4 All

01 4CANAGLIFLOZIN

filter Dosage Reset all filters

4 All

01 4TABLET

filter Exp Date Reset all filters

4 All

01 22024-07-30

02 22027-12-03

Product Main Page

01

Belmore Neidrauer LLP

Canagliflozin

Pharmtech & Ingredients

Not Confirmed

Belmore Neidrauer LLP

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-07-30

Date Granted : 2009-06-02

Canagliflozin

Brand Name : INVOKANA

Patent Number : 2534024

Filing Date : 2004-07-30

Strength per Unit : 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-07-30

Date Granted : 2009-06-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Belmore Neidrauer LLP

Canagliflozin

Pharmtech & Ingredients

Not Confirmed

Belmore Neidrauer LLP

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-03

Date Granted : 2011-11-01

Canagliflozin

Brand Name : INVOKANA

Patent Number : 2671357

Filing Date : 2007-12-03

Strength per Unit : 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-12-03

Date Granted : 2011-11-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Belmore Neidrauer LLP

Canagliflozin

Pharmtech & Ingredients

Not Confirmed

Belmore Neidrauer LLP

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-07-30

Date Granted : 2009-06-02

Canagliflozin

Brand Name : INVOKANA

Patent Number : 2534024

Filing Date : 2004-07-30

Strength per Unit : 300 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-07-30

Date Granted : 2009-06-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Belmore Neidrauer LLP

Canagliflozin

Pharmtech & Ingredients

Not Confirmed

Belmore Neidrauer LLP

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-03

Date Granted : 2011-11-01

Canagliflozin

Brand Name : INVOKANA

Patent Number : 2671357

Filing Date : 2007-12-03

Strength per Unit : 300 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-12-03

Date Granted : 2011-11-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?